Trials / Completed
CompletedNCT03709186
Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI
Radiomic Markers for Breast Cancer Metastasis Using Dynamic Contrast Enhanced MRI and Diffusion-Weighted MRI
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Sunnybrook Health Sciences Centre · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The primary aim of the study is to identify radiomic features as biomarkers of metastatic progression following primary therapy.
Detailed description
The study aims to evaluate radiomic markers in breast tumors to evaluate metastatic risk based on radiomic features following primary therapy. The investigators aim to analyze images at various time intervals before, during and after primary treatments using two advanced imaging techniques (DCE-MRI \& DWI-MRI).
Conditions
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2020-09-01
- Completion
- 2021-01-01
- First posted
- 2018-10-17
- Last updated
- 2023-04-11
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03709186. Inclusion in this directory is not an endorsement.